Jiahong Jiang

1.1k total citations
36 papers, 737 citations indexed

About

Jiahong Jiang is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Jiahong Jiang has authored 36 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 13 papers in Molecular Biology and 11 papers in Cancer Research. Recurrent topics in Jiahong Jiang's work include Pancreatic and Hepatic Oncology Research (7 papers), Cancer-related molecular mechanisms research (7 papers) and Cancer Genomics and Diagnostics (4 papers). Jiahong Jiang is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Cancer-related molecular mechanisms research (7 papers) and Cancer Genomics and Diagnostics (4 papers). Jiahong Jiang collaborates with scholars based in China, United States and Canada. Jiahong Jiang's co-authors include Liu Yang, Xiaoge Hu, Dongsheng Huang, Huaixiang Zhou, Yin‐Yuan Mo, Wan‐Xin Peng, Xinchun Zhou, Chao Ni, Hong Zhu and Ping Zhang and has published in prestigious journals such as Journal of Clinical Oncology, ACS Applied Materials & Interfaces and The Journal of Physical Chemistry C.

In The Last Decade

Jiahong Jiang

32 papers receiving 730 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiahong Jiang China 15 451 372 159 67 55 36 737
Ling Qian China 18 472 1.0× 229 0.6× 203 1.3× 73 1.1× 60 1.1× 24 843
Xin Tian China 17 507 1.1× 395 1.1× 65 0.4× 40 0.6× 75 1.4× 41 764
Yingchen Xu China 16 475 1.1× 322 0.9× 144 0.9× 83 1.2× 81 1.5× 44 797
Guangjian Fan China 14 530 1.2× 260 0.7× 104 0.7× 78 1.2× 106 1.9× 30 876
Jingyi Sheng China 16 694 1.5× 395 1.1× 90 0.6× 101 1.5× 91 1.7× 31 1.2k
Tingting Ma China 22 601 1.3× 515 1.4× 228 1.4× 158 2.4× 117 2.1× 67 1.2k
Deyao Shi China 16 377 0.8× 195 0.5× 115 0.7× 71 1.1× 88 1.6× 36 710
Jer-Wei Chang Taiwan 13 788 1.7× 350 0.9× 199 1.3× 49 0.7× 106 1.9× 22 1.0k

Countries citing papers authored by Jiahong Jiang

Since Specialization
Citations

This map shows the geographic impact of Jiahong Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiahong Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiahong Jiang more than expected).

Fields of papers citing papers by Jiahong Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiahong Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiahong Jiang. The network helps show where Jiahong Jiang may publish in the future.

Co-authorship network of co-authors of Jiahong Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Jiahong Jiang. A scholar is included among the top collaborators of Jiahong Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiahong Jiang. Jiahong Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Jiahong, et al.. (2025). Anticancer therapy-induced peripheral neuropathy in solid tumors: diagnosis, mechanisms, and treatment strategies. Cancer Letters. 620. 217679–217679. 1 indexed citations
2.
Jiang, Jiahong, Xiang Hu, Weihui Yu, et al.. (2023). Brachial-Ankle Pulse Wave Velocity Mediates the Association between Increased Age and Risk of Sarcopenia among Chinese Patients with Type 2 Diabetes Mellitus. Journal of Diabetes Research. 2023. 1–9. 2 indexed citations
3.
Jiang, Jiahong, et al.. (2023). Integrated Analysis of MRNA and MiRNA Expression Profiles in dys-1 Mutants of C. Elegans After Spaceflight and Simulated Microgravity. Microgravity Science and Technology. 35(3). 3 indexed citations
4.
Wang, Nanxi, Fei Wang, Jinlong Liu, et al.. (2023). A parylene-mediated plasmonic–photonic hybrid fiber-optic sensor and its instrumentation for miniaturized and self-referenced biosensing. The Analyst. 148(8). 1672–1681. 3 indexed citations
5.
Zhang, Ping, et al.. (2022). Comparing SARC-CalF With SARC-F for Screening Sarcopenia in Adults With Type 2 Diabetes Mellitus. Frontiers in Nutrition. 9. 803924–803924. 47 indexed citations
6.
Jiang, Jiahong, et al.. (2022). Recent Progress of Research Regarding the Applications of Stem Cells for Treating Diabetes Mellitus. Stem Cells and Development. 31(5-6). 102–110. 12 indexed citations
7.
Peng, Wan‐Xin, Pratirodh Koirala, Huaixiang Zhou, et al.. (2021). Lnc-DC promotes estrogen independent growth and tamoxifen resistance in breast cancer. Cell Death and Disease. 12(11). 1000–1000. 15 indexed citations
8.
Jiang, Jiahong, Yaping Xu, Lianpeng Chang, et al.. (2021). Genomic Landscape in Neoplasm-Like Stroma Reveals Distinct Prognostic Subtypes of Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology. 11. 771247–771247. 1 indexed citations
9.
10.
Ye, Song, Xiaoge Hu, Chao Ni, et al.. (2020). KLF4 p.A472D Mutation Contributes to Acquired Resistance to Cetuximab in Colorectal Cancer. Molecular Cancer Therapeutics. 19(3). 956–965. 8 indexed citations
11.
Jiang, Jiahong, Shaohai Wang, Zehua Wang, et al.. (2020). HOTAIR promotes paclitaxel resistance by regulating CHEK1 in ovarian cancer. Cancer Chemotherapy and Pharmacology. 86(2). 295–305. 23 indexed citations
12.
Zhou, Huaixiang, Xiaoge Hu, Na Li, et al.. (2020). Loganetin and 5‐fluorouracil synergistically inhibit the carcinogenesis of gastric cancer cells via down‐regulation of the Wnt/β‐catenin pathway. Journal of Cellular and Molecular Medicine. 24(23). 13715–13726. 12 indexed citations
13.
Zhang, Yifan, Jianfeng Guo, Jing Cai, et al.. (2020). HOTAIR maintains the stemness of ovarian cancer stem cells via the miR-206/TBX3 axis. Experimental Cell Research. 395(2). 112218–112218. 28 indexed citations
14.
Jiang, Jiahong, Song Ye, Yaping Xu, et al.. (2020). Circulating Tumor DNA as a Potential Marker to Detect Minimal Residual Disease and Predict Recurrence in Pancreatic Cancer. Frontiers in Oncology. 10. 1220–1220. 50 indexed citations
15.
Wang, Mingxing, Yunyun Xu, Min Yang, et al.. (2020). Conversion Therapy for Advanced Pancreatic Cancer: The Case Series and Literature Review. Frontiers in Pharmacology. 11. 579239–579239. 5 indexed citations
16.
Jiang, Jiahong, Huaixiang Zhou, Chao Ni, et al.. (2019). Immunotherapy in pancreatic cancer: New hope or mission impossible?. Cancer Letters. 445. 57–64. 28 indexed citations
17.
Hu, Xiaoge, Jiahong Jiang, Chao Ni, et al.. (2019). HBV Integration-mediated Cell Apoptosis in HepG2.2.15. Journal of Cancer. 10(17). 4142–4150. 19 indexed citations
18.
Hu, Xiaoge, Wan‐Xin Peng, Huaixiang Zhou, et al.. (2019). IGF2BP2 regulates DANCR by serving as an N6-methyladenosine reader. Cell Death and Differentiation. 27(6). 1782–1794. 252 indexed citations
19.
Hu, Xiaoge, Jiahong Jiang, Qiuran Xu, et al.. (2018). A Systematic Review of Long Noncoding RNAs in Hepatocellular Carcinoma: Molecular Mechanism and Clinical Implications. BioMed Research International. 2018. 1–13. 30 indexed citations
20.
Zhou, Huaixiang, Qiuran Xu, Chao Ni, et al.. (2018). Prospects of Noncoding RNAs in Hepatocellular Carcinoma. BioMed Research International. 2018. 1–9. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ling Qian Breakdown of academic impact, for papers by Xin Tian Breakdown of academic impact, for papers by Yingchen Xu Breakdown of academic impact, for papers by Guangjian Fan Breakdown of academic impact, for papers by Jingyi Sheng Breakdown of academic impact, for papers by Tingting Ma Breakdown of academic impact, for papers by Deyao Shi Breakdown of academic impact, for papers by Jer-Wei Chang
Rankless by CCL
2026